
Tata India Pharma & Healthcare Fund (G)
Equity · Sectoral
7.66%
Last 1 year
- Exit Load
- 0.25%
- Expense Ratio
- 2.41%
- Min. AmountMin. SIP Amount
- ₹100
- Min. Lump SumMin. Lump sum
- ₹5,000
Historical View
Return Calculator
- Invested Amount
- ₹9,00,000
- Calculated AmountCurrent Value
- ₹11,66,809
- IRR
- 16.314%
- Absolute Gain
- +₹2,66,809 (+29.6%)
Returns & Rankings
Category: Equity Sectoral


63 ProductsEquity Sectoral Funds


63 ProductsWealthy Score
Return Score rates how well the fund has rewarded investors over time, comparing its returns across periods with other funds in its category.
- 1Y Returns
- 7.7%
- 3Y Returns
- 16.3%
- 5Y Returns
- 13.7%
- Alpha
- 11.7
Holding Analysis
Equity/Debt/Cash Split
- Equity99.7%
- Debt0.3%
Market Cap Weightage
- Small Cap37.1%
- Large Cap31.9%
- Mid Cap30.8%
- Others0.3%
Sector allocation
- Healthcare89.7%
- Materials7.7%
- Consumer Staples2.3%
- Debt0.3%
Top 10 HoldingsTop Holdings
| Stocks | Sector | Percentage |
|---|---|---|
| Sun Pharma.Inds. | Pharmaceuticals | 7.89% |
| Abbott India | Pharmaceuticals | 5.66% |
| Divi's Lab. | Pharmaceuticals | 5.41% |
| Health.Global | Healthcare | 5.25% |
| Dr Reddy's Labs | Pharmaceuticals | 5.14% |
| Torrent Pharma. | Pharmaceuticals | 4.73% |
| Apollo Hospitals | Healthcare | 4.55% |
| Max Healthcare | Healthcare | 4.28% |
| Rainbow Child. | Healthcare | 4.02% |
| Sai Life | Pharmaceuticals | 3.22% |
- 7.89%
Sun Pharma.Inds.
Pharmaceuticals
- 5.66%
Abbott India
Pharmaceuticals
- 5.41%
Divi's Lab.
Pharmaceuticals
- 5.25%
Health.Global
Healthcare
- 5.14%
Dr Reddy's Labs
Pharmaceuticals
Top Funds in the Category
| Fund Name | Rating | Category | 1Y | 3Y |
|---|---|---|---|---|
| — | Equity | 16.23% | 29.6% | |
| — | Equity | 28.41% | 28.89% | |
| — | Equity | 23.71% | 23.26% | |
| — | Equity | 20.06% | 21.85% | |
| — | Equity | 24.28% | 21.75% |
Peer Comparison
Tata India Pharma & Healthcare Fund (G)
- 1 Y Return
- 7.66%
- 3 Y Return
- 16.31%
- 5 Y Return
- 13.67%
Nifty 50
- 1 Y Return
- -2.32%
- 3 Y Return
- 9.41%
- 5 Y Return
- 8.00%
Investment Objective
To seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sector in India.
Fund Management

Rajat Srivastava
From 6thSeptember 2024 onwards With Tata Asset Management Private Limited as Assistant Fund Manager & Research Analyst having responsibilities for Healthcare & Chemicals sector coverage, reporting to Chief Investment Officer - Equities. From October2022 to September 2024 With Incred Asset Management as AVP Investments having responsibilities for Automobile, Healthcare & Diversified sectors reporting to Fund Manager and CEO/CIO. From April 2022 to October 2022 With Kotak Investment Banking as Assistant Vice President-Corporate Advisory having responsibilities for Deal sourcing and reporting to Managing Director-Corporate Advisory Group. From November202 0 to April202 2 With Incred Asset Management as AVP Investments having responsibilities as Healthcare Analyst reporting to Fund Manager. From September20 19 to November 2020 With Emkay Global as Research Associate having responsibilities for coverage of healthcare sector stocks reporting to Lead Analyst. From June 2019 to September 2019 With Evalueserve (Client - Deutsche Securities) as Research Lead having responsibilities for coverage of healthcare/pharma stocks reporting to Lead Analyst. From May 2016 to June20 19 With Motilal Oswal Financial Services as Assistant manager - Research having responsibilities for coverage of healthcare/pharma stocks reporting to Lead Analyst. o
Riskometer
- Risk Score
- 6
- Risk Level
- Very High
Advanced Ratios
- AlphaReturn earned over the benchmark after adjusting for risk. Higher is better.
- 11.70
- BetaHow much the fund moves with the market. Above 1 means more volatile than the market.
- 0.75
- SRSharpe Ratio: return earned per unit of total risk taken. Higher is better.
- 0.72
- SDStandard Deviation: how much returns swing around their average. Lower means steadier returns.
- 16.53
- TRTreynor Ratio: return earned per unit of market risk (beta). Higher is better.
- -0.01
- P/EPrice to Earnings of the stocks the fund holds. Higher means a pricier portfolio.
- 56.82
Tax Implication
STCG Tax: 20% if redeemed before 1 Year. LTCG Tax: 12.5% exceeding Rs. 1,25,000/- post 1 Year
FAQs
Tata India Pharma & Healthcare Fund – Regular Plan - Growth was launched 10 years ago and has delivered annualised returns (CAGR) of 11.67% since inception. Here is how it compares with the category average:
Period Fund Category average 1 Year 7.66% 6.93% 3 Years 16.31% 14.57% 5 Years 13.67% 11.55% Since Inception 11.67% Returns as on 18 Nov 2026. 1-year returns are absolute; returns above 1 year are CAGR. Past performance may or may not be sustained in future.
The expense ratio of Tata India Pharma & Healthcare Fund – Regular Plan - Growth is 2.41%. This is the annual fee for managing and operating the fund. It is adjusted in the daily NAV, so the returns you see are already net of this cost.
Tata India Pharma & Healthcare Fund is rated Very High risk on the SEBI riskometer. The riskometer has six levels, from Low to Very High, and fund houses review it every month.
You can start an SIP in Tata India Pharma & Healthcare Fund with ₹100 a month, or invest a lump sum of ₹5,000. Additional investments start at ₹1,000.
Tata India Pharma & Healthcare Fund charges an exit load of 0.25% if redeemed within 30 days of investment. The exit load is deducted from the redemption amount.
No, Tata India Pharma & Healthcare Fund has no lock-in period, so you can redeem anytime. An exit load may apply on early redemption.
Tata India Pharma & Healthcare Fund manages assets (AUM) of approximately ₹1,499 Cr.
As on 31 Oct 2026, Tata India Pharma & Healthcare Fund holds 42 securities. These are its top 10 holdings:
Company % of portfolio Sun Pharma.Inds. 7.89% Abbott India 5.66% Divi's Lab. 5.41% Health.Global 5.25% Dr Reddy's Labs 5.14% Torrent Pharma. 4.73% Apollo Hospitals 4.55% Max Healthcare 4.28% Rainbow Child. 4.02% Sai Life 3.22% As on 31 Oct 2026, these are the fund's largest sector allocations:
Sector % of portfolio Healthcare 89.74% Materials 7.66% Consumer Staples 2.34% Debt 0.26% If you invested through a Wealthy partner, you can place a redemption request in the Wealthy app, or ask your partner to do it for you. If you invested elsewhere, you can redeem through the Tata Mutual Fund website, MF Central or CAMS. The money is credited to your registered bank account, usually within a few working days. Exit load and capital gains tax may apply.












